Covered recipient · General Payments record
NGOZIKA UGONWA ANUSIONWU
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$300.52
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $278.52 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $81.82 | 4 |
| Amgen Inc. | $56.42 | 3 |
| Lilly USA, LLC | $56.20 | 3 |
| GlaxoSmithKline, LLC. | $22.05 | 1 |
| Astellas Pharma US Inc | $18.93 | 1 |
| Acerta Pharma LLC | $14.75 | 1 |
| Novo Nordisk AS | $14.50 | 1 |
| Sumitomo Pharma America, Inc. | $13.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.41 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232469 | CMS |
| ABBVIE INC. | $22.05 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232471 | CMS |
| ABBVIE INC. | $13.91 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232473 | CMS |
| ABBVIE INC. | $21.45 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232475 | CMS |
| Amgen Inc. | $24.00 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117495636 | CMS |
| Amgen Inc. | $17.80 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117495638 | CMS |
| Amgen Inc. | $14.62 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115426874 | CMS |
| Astellas Pharma US Inc | $18.93 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139363247 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.75 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105431569 | CMS |
| GlaxoSmithKline, LLC. | $22.05 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116643662 | CMS |
| Lilly USA, LLC | $23.25 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135279080 | CMS |
| Lilly USA, LLC | $19.55 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135282709 | CMS |
| Lilly USA, LLC | $13.40 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135282712 | CMS |
| Novo Nordisk Inc | $14.50 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097322063 | CMS |
| Sumitomo Pharma America, Inc. | $13.85 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148821966 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2024
- Source files
- Dataset page · Bulk file · PY2019 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.